These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 23876340)
1. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340 [TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effect of a newly developed AMP-activated protein kinase activator YLF-466D. Liu Y; Park JM; Oh SJ; Chang KH; Lee MY Eur J Pharmacol; 2015 Aug; 760():81-7. PubMed ID: 25913239 [TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051 [TBL] [Abstract][Full Text] [Related]
4. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Lira VA; Soltow QA; Long JH; Betters JL; Sellman JE; Criswell DS Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1062-8. PubMed ID: 17666490 [TBL] [Abstract][Full Text] [Related]
6. Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes. McConell GK; Ng GP; Phillips M; Ruan Z; Macaulay SL; Wadley GD J Appl Physiol (1985); 2010 Mar; 108(3):589-95. PubMed ID: 20044477 [TBL] [Abstract][Full Text] [Related]
7. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change. Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F Platelets; 2011; 22(1):8-19. PubMed ID: 20958117 [TBL] [Abstract][Full Text] [Related]
8. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells. Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104 [TBL] [Abstract][Full Text] [Related]
9. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698 [TBL] [Abstract][Full Text] [Related]
15. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Zhuge J Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182 [TBL] [Abstract][Full Text] [Related]
17. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats. Oki K; Arias EB; Kanzaki M; Cartee GD Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344 [TBL] [Abstract][Full Text] [Related]
18. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase. Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081 [TBL] [Abstract][Full Text] [Related]
19. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway. Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483 [TBL] [Abstract][Full Text] [Related]
20. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. Shearer J; Fueger PT; Rottman JN; Bracy DP; Martin PH; Wasserman DH Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E871-7. PubMed ID: 15265760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]